Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma

Guoyu Huang1, Feifei Cui1, Fudong Yu1

  • 1Department of General Surgery, First People's Hospital, Shanghai Jiao Tong Univerisity, 85 Wujin Road, Shanghai 200080, China.

Abstract

Insights

SIRT4, a tumor suppressor, is significantly lower in gastric adenocarcinoma tissues compared to normal tissues. Reduced SIRT4 expression correlates with advanced disease, suggesting its potential as a diagnostic biomarker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Sirtuins (SIRTs) are NAD(+)-dependent enzymes crucial in tumor formation.
  • SIRT4 is implicated in glutamine metabolism and possesses tumor suppressor functions.
  • Limited understanding exists regarding SIRT4 expression and its clinicopathological correlations in gastric cancer.

Purpose of the Study:

  • To investigate SIRT4 protein expression in gastric adenocarcinoma.
  • To determine the association between SIRT4 levels and clinicopathological parameters in gastric adenocarcinoma.

Main Methods:

  • Immunohistochemical staining of SIRT4 protein on tissue microarrays from 75 gastric adenocarcinoma patients.
  • Analysis of SIRT4 expression in tumor tissues versus adjacent normal gastric tissues.
  • Correlation analysis between SIRT4 expression and clinicopathological features.

Main Results:

  • SIRT4 protein expression was significantly lower in gastric adenocarcinoma compared to normal gastric tissues (P=0.003).
  • Lower SIRT4 levels correlated with higher pathological grade (P=0.002), deeper tumor invasion (P=0.034), more positive lymph nodes (P=0.005), and advanced UICC stage (P=0.002).

Conclusions:

  • SIRT4 functions as a tumor suppressor in human gastric tissues.
  • SIRT4 is involved in gastric adenocarcinoma development.
  • SIRT4 may serve as a potential diagnostic biomarker and therapeutic target for gastric adenocarcinoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K